SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Reviva Pharmaceuticals Holdings, Inc. – RVPH
NEW YORK, May 30, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Reviva Pharmaceuticals Holdings, Inc. (“Reviva” or the “Company”) (NASDAQ: RVPH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-5
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, Inc. – SAGE
NEW YORK, May 30, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. (“Sage” or the “Company”) (NASDAQ: SAGE). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Jabil Inc. – JBL
NEW YORK, May 30, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Jabil Inc. (“Jabil” or the “Company”) (NYSE: JBL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The in
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Hertz Global Holdings, Inc. – HTZ
NEW YORK, May 30, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Hertz Global Holdings, Inc. (“Hertz” or the “Company”) (NASDAQ: HTZ). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980,
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zoetis Inc. – ZTS
NEW YORK, May 30, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Zoetis Inc. (“Zoetis” or the “Company”) (NYSE: ZTS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The i
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of CVRx, Inc. – CVRX
NEW YORK, May 30, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of CVRx, Inc. (“CVRx” or the “Company”) (NASDAQ: CVRX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The i
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Deutsche Bank Aktiengesellschaft – DB
NEW YORK, May 30, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Deutsche Bank Aktiengesellschaft (“Deutsche Bank” or the “Company”) (NYSE: DB). Such investors are advised to contact Danielle Peyton at [email protected] or 6
Clara Gutsche wins the 14th annual Scotiabank Photography Award
TORONTO, May 30, 2024 /CNW/ – Clara Gutsche of Montréal, Québec is the winner of the 14th annual Scotiabank Photography Award. As winner of the prestigious Award, Gutsche will receive a $50,000 cash prize, a solo Primary Exhibition during the 2025 CONTACT Photography Festival, and a publishe
Telix Announces Positive rPFS Data from ProstACT SELECT Trial of TLX591 rADC Therapy Candidate in Prostate Cancer
TLX591 is an investigational anti-PSMA[1] radio-antibody-drug conjugate (rADC) therapy being developed for the treatment of mCRPC, differentiated by a short two-week dosing regimen.Reported median radiographic progression-free survival (rPFS) is 8.8 months.Builds on prior data from the ProstACT SELE
Lotus Digital Expands Portfolio and Offerings in Rebrand to Noblestream Marketing
ORLANDO, Fla., May 30, 2024 /PRNewswire/ — Lotus Digital is excited to announce its rebrand to Noblestream Marketing, reflecting an expansion of its solution portfolio to more broadly serve its clients. The transition to Noblestream Marketing marks a significant milestone in the company’
